411/420 | Cannabis Drug Scheduling | CashCropToday
0 Shares 2366 Views

411/420 | Cannabis Drug Scheduling

February 13, 2018
2366 Views

411/420 Host Joya Mia Italiano discusses drug scheduling and the uproar of Cannabis being classed with harder “drugs”. Get “The Downlow on the Business of Getting High” by tuning into 411/420

Tune In To New Episodes of 411/420 Thursdays, Exclusively on Cashcroptoday.com

CashCropToday Media is a global media, branding and technology company, with a focus on news and information about investing, technology, entrepreneurship, and the lifestyle of Cannabis & Hemp.
Reaching more than 1.2 million people worldwide, CashCropToday offers news coverage focused on Investing in Cannabis & Hemp through public traded companies, political opinions, and documentary programming, 7 days a week.

Connect with CashCropToday
Find us on Facebook: https://www.facebook.com/cashcroptoday
Follow us on Twitter: https://twitter.com/cashcroptoday
Follow us on Instagram: https://www.instagram.com/cashcroptoday

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
269 views
Market Watch
269 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
191 views
Global
191 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
189 views
Manufacturing
189 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: